Is Zepbound the Same as Mounjaro? The UK Answer

Step 1: Understand why two names exist for the same medicine

Pharmaceutical companies often register separate brand names in different markets. Eli Lilly launched tirzepatide in the United States under the name Zepbound specifically for weight management, and you can find a full breakdown on our tirzepatide Zepbound page, while the name Ozempic versus Wegovy illustrates the same pattern for semaglutide. In the UK, Eli Lilly chose Mounjaro as the brand for tirzepatide across both its weight-management and type 2 diabetes licences. The molecule, the dose strengths and the pre-filled KwikPen delivery system are the same; only the packaging and the regulatory approval geography differ.

This distinction matters practically. If you have read about Zepbound in American news coverage or social media, the clinical evidence you have seen (including the SURMOUNT trial programme, which randomised thousands of adults with obesity and reported average body-weight reductions of around 20–21% at the 15 mg dose) applies equally to Mounjaro in the UK, because the studies used tirzepatide regardless of which brand name later appeared on the box. You can read the detail on our tirzepatide overview page.

So when people ask whether tirzepatide is the same as Zepbound, our page on how these medicines compare explains that the answer is yes in terms of chemistry and clinical evidence, but the product you would actually receive in the UK is Mounjaro, supplied through the UK-licensed supply chain.

Step 2: Recognise that Zepbound has no UK licence

The MHRA is the body that licenses medicines for use in the UK, and Zepbound has never been submitted for or granted a UK marketing authorisation. This is not a technicality. A medicine without a UK licence has not been assessed by UK regulators for the quality, safety and efficacy standards required under the Human Medicines Regulations 2012. Importing or supplying it outside those rules would be unlicensed and potentially unsafe.

The MHRA has warned publicly about the risks of sourcing weight-loss medicines through unverified online channels, including products sold under foreign brand names. Counterfeit and unlicensed pens have been seized in significant quantities, and some have been found to contain harmful substances. If you come across a seller offering Zepbound for delivery to a UK address, that is a clear signal the supply chain is not operating within UK law. Report suspect sellers at the MHRA's Yellow Card scheme.

The safe, legal route to tirzepatide in the UK is a prescription for Mounjaro, issued after a clinical assessment by a registered prescriber. Details of what that assessment involves are explained on our tirzepatide and Mounjaro comparison page.

Step 3: Know which medicines are actually licensed for weight loss in the UK

Two injectable medicines currently hold UK licences for weight management in adults: Mounjaro (tirzepatide, Eli Lilly) and Wegovy (semaglutide, Novo Nordisk). A third option, Wegovy tablets (oral semaglutide) received MHRA approval in June 2026, making it the first oral GLP-1 medicine licensed for weight loss in the UK. Orlistat is separately available for weight management in capsule form.

Ozempic, which also contains semaglutide, is licensed for type 2 diabetes rather than weight loss, and the same applies to Rybelsus (oral semaglutide at lower doses). Neither should be sought for weight management. You can explore the full picture of licensed options on our weight-loss treatments overview.

For anyone wondering about cost alongside the clinical picture, our page on how Zepbound differs from Mounjaro covers the pricing context too, including why Mounjaro's UK list price changed substantially in late 2025. Worth a read before drawing comparisons with US prices you may have seen quoted for Zepbound.

Step 4: What to do if you want to start Mounjaro in the UK

Because Mounjaro is a prescription-only medicine, the starting point is always a clinical consultation. A prescriber considers your BMI, medical history, current medications and any conditions that might affect suitability. There is no shortcut to this, and no legitimate pharmacy can supply it without one.

At nume, every consultation is read by a GPhC-registered Independent Prescriber on the same day it is submitted, a real clinician reviews your answers, not an automated system. Our clinical team page explains who oversees prescribing at our pharmacy. Once approved, orders placed before 12pm on a working day are dispatched the same day through DPD, arriving the next working day in plain packaging. There are no subscriptions; each repeat order goes through clinical review again before anything is sent.

If you are unsure whether Mounjaro is right for your situation, or you have questions about eligibility, our FAQs are a good starting point. Otherwise, the clearest next step is a free consultation with our prescribers, where your specific circumstances can be assessed properly. You can check your eligibility and speak to our prescribers here.